Modified Albumin-Bilirubin Grade optimized for risk stratification of patients with stage II-III gastric cancer

Surg Today. 2023 Oct;53(10):1149-1159. doi: 10.1007/s00595-023-02669-x. Epub 2023 Mar 24.

Abstract

Purpose: The albumin-bilirubin (ALBI) grade is calculated using albumin and bilirubin values. We determined the optimal cutoff value of the ALBI grade for predicting the postoperative prognosis of gastric cancer (GC).

Methods: We retrospectively reviewed a multicenter database of 3571 patients who underwent gastrectomy for GC between January 2010 and December 2014. The modified ALBI (mALBI) grade was determined using cutoff values: grade 1 (mALBI ≤ - 2.70), 2 (mALBI - 2.70 to - 2.10), and 3 (mALBI > - 2.10). We used a validation cohort to evaluate reproducibility.

Results: The entire cohort (n = 956) was randomly assigned to the learning or validation cohorts (n = 478 each). The former was categorized into the following groups by the preoperative mALBI grade: grade 1 (n = 235), grade 2 (n = 162), and grade 3 (n = 81). The disease-specific survival (DSS) rates of the learning and validation cohorts were significantly shortened in association with higher mALBI grade (learning, p = 0.0068; validation, p = 0.0100). A multivariate analysis revealed that mALBI grade 3 served as an independent prognostic factor for DSS. Furthermore, mALBI grade 2 or 3 was associated with a greater risk of disease-specific death in most subgroups.

Conclusion: The mALBI grade accurately predicted the long-term postoperative prognosis of locally advanced GC.

Keywords: Albumin–Bilirubin Grade; Gastric cancer; Liver failure; Malnutrition; Prognosis.

Publication types

  • Multicenter Study

MeSH terms

  • Bilirubin
  • Carcinoma, Hepatocellular* / surgery
  • Humans
  • Liver Neoplasms* / surgery
  • Prognosis
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Assessment
  • Serum Albumin
  • Stomach Neoplasms* / surgery

Substances

  • Bilirubin
  • Serum Albumin